https://ono-7300243antagonist.....com/study-data-and-m
Recent studies on modified translational legislation during pathological cardiac hypertrophy are contributing to our understanding of disease progression. In this brief review, we explain how the translational equipment is modulated for enhanced international and transcript selective protein synthesis, and exactly how alternative modes of translation donate to the disease condition. Attempts at managing translational output through targeting of mTOR and its regulating components are detailed, also recently